DTIL biotech catalysts & pipeline

PRECISION BIOSCIENCES INC · Data as of 2026-09-08

Upcoming catalysts

PBGENE-DMD — Topline data

Late 2026

Next PBGENE-HBV and PBGENE-DMD clinical updates targeted for year-end 2026 -

Source filing

PBGENE-HBV — Topline data

Late 2026

Next PBGENE-HBV and PBGENE-DMD clinical updates targeted for year-end 2026 -

Source filing

azercabtagene zapreleucel — Conference presentation

H2 2026

Anticipated 2026 events include presentation of preliminary Phase 1 azer-cel data in progressive multiple sclerosis in the second half of 2026 and commencement of additional exploratory studies in autoimmune diseases outside of multiple sclerosis.

Source filing

Explore the free biotech catalyst calendar